Financials data is unavailable for this security.
View more
Year on year Ohki Healthcare Holdings Co Ltd had no change in net income (2.21bn) despite revenues that grew 9.92% from 304.45bn to 334.66bn. A contributing factor has been an increase in the cost of goods sold as a percent of sales from 94.78% to 94.86%.
| Gross margin | 5.11% |
|---|---|
| Net profit margin | 0.59% |
| Operating margin | 0.61% |
| Return on assets | 1.49% |
|---|---|
| Return on equity | 7.78% |
| Return on investment | 6.44% |
More ▼
Cash flow in JPYView more
In 2024, Ohki Healthcare Holdings Co Ltd increased its cash reserves by 156.42%, or 5.07bn. The company earned 7.55bn from its operations for a Cash Flow Margin of 2.26%. In addition the company used 496.00m on investing activities and also paid 2.00bn in financing cash flows.
| Cash flow per share | 172.88 |
|---|---|
| Price/Cash flow per share | 5.54 |
| Book value per share | 2,077.28 |
|---|---|
| Tangible book value per share | 2,065.85 |
More ▼
Balance sheet in JPYView more
| Current ratio | 1.12 |
|---|---|
| Quick ratio | 0.8853 |
| Total debt/total equity | 0.2049 |
|---|---|
| Total debt/total capital | 0.1698 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 9.09% and 1.40%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 2.31% |
|---|---|
| Div growth rate (5 year) | 5.92% |
| Payout ratio (TTM) | 15.70% |
| EPS growth(5 years) | 1.83 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -11.24 |
More ▼
